Clinical Trials Directory

Trials / Sponsors / XIANG YANQUN

XIANG YANQUN

Academic / Other · 6 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingEfficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A
Nasopharyngeal Carcinoma
Phase 32024-05-30
Active Not RecruitingIrinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Ca
Nasopharyngeal Cancer
Phase 22024-05-22
RecruitingTislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Met
Nasopharyngeal Carcinoma
Phase 32024-05-15
Active Not RecruitingMaintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasophary
Nasopharyngeal Carcinoma, Maintenance Therapy
Phase 32023-04-28
UnknownPD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal
Nasopharyngeal Carcinoma, T2-3N0 or T1-2N1, EBV-DNA≤4000 Copy/ml
Phase 22022-03-12
UnknownEfficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Pla
Metastatic Nasopharyngeal Carcinoma, Chemotherapy Effect
Phase 22021-07-29